A Novel A-Kinase-Anchoring Protein 9 Variant in Premature Coronary Artery Disease: A Case Series

Yuemiao Jiao1, Minxian Wang2,3, Guifen Qiang4

  • 1Department of Interventional Center of Valvular Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Insights

A genetic variant in the AKAP9 gene (c.6406C>G) is linked to familial premature coronary artery disease (CAD) in a Chinese pedigree. This AKAP9 variant may be a causal factor for premature CAD in this population.

Area of Science:

  • Genetics
  • Cardiology
  • Molecular Biology

Background:

  • Familial premature coronary artery disease (CAD) is frequently linked to specific genetic variations.
  • Investigating genetic factors is crucial for understanding the etiology of early-onset heart disease.

Purpose of the Study:

  • To identify potential causal genetic variants associated with premature coronary artery disease (CAD) within a Chinese family.
  • To explore the genetic underpinnings of familial premature CAD.

Main Methods:

  • Whole-exome sequencing (WES) was conducted on six family members (four with premature CAD, two controls).
  • Candidate variant validation was performed using Sanger sequencing in four family members.
  • Functional analysis was employed to assess the impact of the identified variant.

Main Results:

  • A significant linkage was found between the c.6406C>G variant in the AKAP9 gene and premature CAD in the studied pedigree.
  • The c.6406C>G variant in AKAP9 was observed to reduce the interaction between AKAP9 and PRKAR2A.
  • This genetic association was specifically identified in patients with premature CAD.

Conclusions:

  • The c.6406C>G variant within the AKAP9 gene is suggested as a potential causal factor for premature coronary artery disease (CAD).
  • These findings highlight the role of AKAP9 genetic variations in the development of premature CAD within the Chinese population.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
922
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
391
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.0K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.4K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
223
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
345